PRESS RELEASE published on 10/02/2026 at 07:00, 15 days 4 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce un amortissement anticipé partiel de son Financement Obligataire, réservé à Fenja Capital II A/S, avec émission d'Actions Nouvelles Actions Nouvelles Financement Obligataire ABIONYX Pharma Amortissement Anticipé Fenja
PRESS RELEASE published on 10/02/2026 at 07:00, 15 days 4 hours ago Inside Information / Other news releases ABIONYX Pharma settles anticipated amortization payment under bonds financing agreement, issuing new ordinary shares to Fenja Capital and maintaining unchanged projected cash runway into Q4 2028 ABIONYX Pharma Cash Runway New Ordinary Shares Bonds Financing Amortization Payment
BRIEF published on 09/23/2026 at 21:41, 23 days 13 hours ago ABIONYX Pharma Reports Half-Year Results for 2026 Financial Results Biopharmaceuticals Revenue Report LCAT Deficiency Sepsis Research
BRIEF published on 09/23/2026 at 21:41, 23 days 13 hours ago ABIONYX: 2026 Half-Year Results and Future Strategies Research And Development Treasury France 2030 ABIONYX Pharma 2026 Financial Results
BRIEF published on 09/23/2026 at 21:41, 23 days 13 hours ago ABIONYX Pharma publie ses résultats semestriels pour 2026 Résultats Financiers Produits Biopharmaceutiques Rapport Sur Les Revenus Recherche Sur La Septicémie Déficit En LCAT
BRIEF published on 09/23/2026 at 21:41, 23 days 13 hours ago ABIONYX : Résultats Semestriels 2026 et Stratégies Future Recherche Et Développement Trésorerie France 2030 ABIONYX Pharma Résultats Financiers 2026
PRESS RELEASE published on 09/23/2026 at 21:36, 23 days 13 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce ses résultats financiers du 1er semestre 2026 avec une trésorerie de 26,9 M€ avant encaissement des Crédits d’Impôt Recherche et des aides du plan France 2030, perspectives axées sur l'exécution des programmes Résultats Financiers Trésorerie Plan France 2030 ABIONYX Pharma Sepsis
PRESS RELEASE published on 09/23/2026 at 21:36, 23 days 13 hours ago Inside Information / Other news releases ABIONYX Pharma announces half-year financial results for 2026 with emphasis on cash balance, revenue, and expenses. Focus on innovative therapies for sepsis and LCAT deficiency under France 2030 plan Half-year Results France 2030 Plan ABIONYX Pharma Sepsis LCAT Deficiency
BRIEF published on 08/27/2026 at 19:04, 1 month 20 days ago ABIONYX Pharma fait le point sur ses résultats financiers de mi-année 2026 Mise À Jour Financière Ophtalmologie ABIONYX Pharma Position De Trésorerie Recettes De 2026
BRIEF published on 08/27/2026 at 19:04, 1 month 20 days ago ABIONYX Pharma Updates on Mid-Year 2026 Financials Cash Position Financial Update Ophthalmology ABIONYX Pharma 2026 Revenue
Published on 10/17/2026 at 03:20, 7 hours 40 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 7 hours 45 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 11 hours 25 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 11 hours 30 minutes ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 12 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/16/2026 at 20:08, 14 hours 51 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 15 hours 39 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 15 hours 54 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 16 hours 41 minutes ago Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 16 hours 46 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 19:54, 15 hours 5 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 16 hours 11 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 16 hours 11 minutes ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
